Full-Time

Solution Architect

Erp

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Compensation Overview

$117.1k - $146.4k/yr

Senior, Expert

Company Historically Provides H1B Sponsorship

Austin, TX, USA + 1 more

More locations: San Carlos, CA, USA

Candidates must be based in the US for this remote position.

Category
Solution Engineering
Sales & Solution Engineering
Required Skills
Supply Chain Management
Oracle
Requirements
  • In-depth knowledge of Supply Chain Management modules, including Product Data Management, Procurement, Inventory, Order Management, Manufacturing, and Planning.
  • Strong experience with Finance modules, including General Ledger, Accounts Payable, and Receivable.
  • Hands-on experience with Oracle’s reporting tools (BI Publisher, OTBI, FRS).
  • Expertise in Oracle Integration Cloud (OIC), APIs, and web services.
  • Familiarity with data migration tools and processes in Oracle Fusion.
  • Knowledge of RICE-W components and the ADF framework.
  • Deep understanding of Procure-to-Pay, Order-to-Cash, Record-to-Report, and Inventory Management processes.
  • Ability to guide development teams on best practices for Oracle Fusion customizations and extensions.
  • Strong troubleshooting and problem-solving skills for complex configurations and integrations.
  • Strong interpersonal and communication skills to engage effectively with business stakeholders, technical teams, and leadership.
  • Proven ability to work in a fast-paced, cross-functional environment while managing multiple priorities.
  • An analytical mindset with a focus on scalable and efficient solutions.
Responsibilities
  • Lead the design of comprehensive solutions within Oracle Fusion Cloud, emphasizing Supply Chain Management modules and Finance modules.
  • Translate business requirements into technical specifications and high-level designs.
  • Collaborate with business stakeholders, BSAs, and technical teams to define priorities and deliverables.
  • Guide BSAs in requirement gathering, gap analysis, and functional design.
  • Coordinate with technical teams on integrations, extensions, and data migration efforts.
  • Ensure alignment with Oracle's best practices and architectural principles.
  • Oversee the development of reports, interfaces, customizations, and extensions (RICE-W components).
  • Guide and review technical implementations, including APIs, workflows, and third-party system integrations.
  • Evaluate existing Oracle Fusion Cloud configurations and recommend enhancements to improve performance and scalability.
  • Ensure solutions support long-term business goals and compliance requirements.
  • Act as the primary liaison between IT and business teams, ensuring alignment and understanding of solution designs.
  • Present architectural recommendations to leadership and gain approval for proposed solutions.
  • Develop and maintain architectural documentation, including solution diagrams, data models, and functional/technical specifications.
  • Participate in project planning, risk assessments, and status reviews.
Desired Qualifications
  • Oracle certifications in SCM or Financials.
  • Experience with agile project methodologies.
  • Familiarity with industry standards and compliance requirements (e.g., SOX, GDPR).
  • Background in healthcare, manufacturing, or related industries.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing kits and services, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's custom-built ctDNA tests.

What critics are saying

  • Increased competition from companies like Lantheus Holdings threatens market share.
  • Recent CFO stock sale may indicate concerns about Natera's financial health.
  • Multiple trial launches could strain resources and lead to operational challenges.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical needs.
  • Their Signatera test offers custom-built ctDNA solutions for cancer patients.
  • Natera's Panorama NIPT has achieved over 2 million tests conducted.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

5%
TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.

Simply Wall St
Mar 13th, 2025
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.

Investing.com
Mar 10th, 2025
Natera launches HEROES trial for breast cancer treatment

Natera launches HEROES trial for breast cancer treatment.